85 related articles for article (PubMed ID: 31359406)
1. Radioresistance of KRAS/TP53-mutated lung cancer can be overcome by radiation dose escalation or EGFR tyrosine kinase inhibition in vivo.
Gurtner K; Kryzmien Z; Koi L; Wang M; Benes CH; Hering S; Willers H; Baumann M; Krause M
Int J Cancer; 2020 Jul; 147(2):472-477. PubMed ID: 31359406
[TBL] [Abstract][Full Text] [Related]
2. Synergy of EGFR and AURKA Inhibitors in KRAS-mutated Non-small Cell Lung Cancers.
Bagnyukova T; Egleston BL; Pavlov VA; Serebriiskii IG; Golemis EA; Borghaei H
Cancer Res Commun; 2024 May; 4(5):1227-1239. PubMed ID: 38639476
[TBL] [Abstract][Full Text] [Related]
3. EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiation.
Wang M; Kern AM; Hülskötter M; Greninger P; Singh A; Pan Y; Chowdhury D; Krause M; Baumann M; Benes CH; Efstathiou JA; Settleman J; Willers H
Cancer Res; 2014 May; 74(10):2825-34. PubMed ID: 24648348
[TBL] [Abstract][Full Text] [Related]
4. Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer.
Bischoff P; Reck M; Overbeck T; Christopoulos P; Rittmeyer A; Lüders H; Kollmeier J; Kulhavy J; Kemper M; Reinmuth N; Röper J; Janning M; Sommer L; Aguinarte L; Koch M; Wiesweg M; Wesseler C; Waller CF; Kauffmann-Guerrero D; Stenzinger A; Stephan-Falkenau S; Trautmann M; Lassmann S; Tiemann M; Klauschen F; Sebastian M; Griesinger F; Wolf J; Loges S; Frost N;
J Thorac Oncol; 2024 May; 19(5):803-817. PubMed ID: 38096950
[TBL] [Abstract][Full Text] [Related]
5. Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy.
Shepherd FA; Lacas B; Le Teuff G; Hainaut P; Jänne PA; Pignon JP; Le Chevalier T; Seymour L; Douillard JY; Graziano S; Brambilla E; Pirker R; Filipits M; Kratzke R; Soria JC; Tsao MS;
J Clin Oncol; 2017 Jun; 35(18):2018-2027. PubMed ID: 28453411
[TBL] [Abstract][Full Text] [Related]
6. Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells.
Mantovani FB; Morrison JA; Mutsaers AJ
BMC Vet Res; 2016 May; 12():82. PubMed ID: 27245053
[TBL] [Abstract][Full Text] [Related]
7. Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer.
You S; Li R; Park D; Xie M; Sica GL; Cao Y; Xiao ZQ; Deng X
Mol Cancer Ther; 2014 Mar; 13(3):606-16. PubMed ID: 24362463
[TBL] [Abstract][Full Text] [Related]
8. KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma.
Budczies J; Romanovsky E; Kirchner M; Neumann O; Blasi M; Schnorbach J; Shah R; Bozorgmehr F; Savai R; Stiewe T; Peters S; Schirmacher P; Thomas M; Kazdal D; Christopoulos P; Stenzinger A
Br J Cancer; 2024 Jun; ():. PubMed ID: 38866964
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitization of Hs-766T Pancreatic Tumor Xenografts in Mice Dosed with Dodecafluoropentane Nano-Emulsion-Preliminary Findings.
Johnson JL; Leos RA; Baker AF; Unger EC
J Biomed Nanotechnol; 2015 Feb; 11(2):274-81. PubMed ID: 26349303
[TBL] [Abstract][Full Text] [Related]
10. Primary Prevention and Interception Studies in RAS-Mutated Tumor Models Employing Small Molecules or Vaccines.
Dragnev KH; Lubet RA; Miller MS; Sei S; Fox JT; You M
Cancer Prev Res (Phila); 2023 Oct; 16(10):549-560. PubMed ID: 37468135
[TBL] [Abstract][Full Text] [Related]
11. Spectroscopic investigation of radiation-induced reoxygenation in radiation-resistant tumors.
Dadgar S; Troncoso JR; Siegel ER; Curry NM; Griffin RJ; Dings RPM; Rajaram N
Neoplasia; 2021 Jan; 23(1):49-57. PubMed ID: 33220616
[TBL] [Abstract][Full Text] [Related]
12. Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer.
Fujimoto TN; Colbert LE; Huang Y; Molkentine JM; Deorukhkar A; Baseler L; de la Cruz Bonilla M; Yu M; Lin D; Gupta S; Cabeceiras PK; Kingsley CV; Tailor RC; Sawakuchi GO; Koay EJ; Piwnica-Worms H; Maitra A; Taniguchi CM
Cancer Res; 2019 May; 79(9):2327-2338. PubMed ID: 31043430
[TBL] [Abstract][Full Text] [Related]
13. Supramolecular Probes for Assessing Glutamine Uptake Enable Semi-Quantitative Metabolic Models in Single Cells.
Xue M; Wei W; Su Y; Johnson D; Heath JR
J Am Chem Soc; 2016 Mar; 138(9):3085-93. PubMed ID: 26916347
[TBL] [Abstract][Full Text] [Related]
14. The Beneficial Role of Sunitinib in Tumor Immune Surveillance by Regulating Tumor PD-L1.
Li H; Kuang X; Liang L; Ye Y; Zhang Y; Li J; Ma F; Tao J; Lei G; Zhao S; Su J; Yang N; Peng C; Xu X; Hung MC; Han L; Liu H; Liu J; Chen X
Adv Sci (Weinh); 2021 Jan; 8(2):2001596. PubMed ID: 33510997
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy enhances uptake and efficacy of
Dietrich A; Andreeff M; Koi L; Bergmann R; Schubert M; Schreiner L; Löck S; Sihver W; Freudenberg R; Hering S; Pietzsch HJ; Steinbach J; Kotzerke J; Baumann M; Krause M
Radiother Oncol; 2021 Feb; 155():285-292. PubMed ID: 33227356
[TBL] [Abstract][Full Text] [Related]
16. TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG).
Werbrouck C; Evangelista CCS; Lobón-Iglesias MJ; Barret E; Le Teuff G; Merlevede J; Brusini R; Kergrohen T; Mondini M; Bolle S; Varlet P; Beccaria K; Boddaert N; Puget S; Grill J; Debily MA; Castel D
Clin Cancer Res; 2019 Nov; 25(22):6788-6800. PubMed ID: 31481512
[TBL] [Abstract][Full Text] [Related]
17. Screening and Validation of Molecular Targeted Radiosensitizers.
Willers H; Pan X; Borgeaud N; Korovina I; Koi L; Egan R; Greninger P; Rosenkranz A; Kung J; Liss AS; Parsels LA; Morgan MA; Lawrence TS; Lin SH; Hong TS; Yeap BY; Wirth LJ; Hata AN; Ott CJ; Benes CH; Baumann M; Krause M
Int J Radiat Oncol Biol Phys; 2021 Dec; 111(5):e63-e74. PubMed ID: 34343607
[TBL] [Abstract][Full Text] [Related]
18. Histology-driven hypofractionated radiation therapy schemes for early-stage lung adenocarcinoma and squamous cell carcinoma.
Liu F; Farris MK; Ververs JD; Hughes RT; Munley MT
Radiother Oncol; 2024 Jun; 195():110257. PubMed ID: 38548113
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in molecular targeted therapy of lung cancer: Possible application in translation medicine.
Salmani-Javan E; Farhoudi Sefidan Jadid M; Zarghami N
Iran J Basic Med Sci; 2024; 27(2):122-133. PubMed ID: 38234663
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the tumor microenvironment and the efficacy of the combination of radiotherapy and immunotherapy.
Su C; Himes JE; Kirsch DG
Int Rev Cell Mol Biol; 2023; 378():201-232. PubMed ID: 37438018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
